Epoprostenol API Manufacturers

Wiki Information	Epoprostenol API Manufacturers
Indication & Benefits	Epoprostenol is an intravenous medication approved for the treatment of pulmonary arterial hypertension (PAH) in World Health Organization (WHO) Group 1 patients. Epoprostenol is a synthetic analogue of prostacyclin, a naturally occurring substance in the body, which has effects on dilating blood vessels.
How To Use
Deficiency
Recommended For Better
Pregnancy Warning
Side Effects
Disclaimer	Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement.
Products